Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Meritage Homes $575 million convertible notes offering
The 1.75% convertible senior notes are due 2028
SS&C Technologies $750 million senior notes offering
We advised SS&C Technologies on the high-yield debt offering
ZEEKR Intelligent Technology $441 million IPO
We advised ZEEKR on its IPO and NYSE listing
Mastercard $1 billion senior notes offering
We advised Mastercard on its investment-grade debt offering
Visa Class B stockholder liquidity program and $100 billion exchange offer
We advised Visa on the design and implementation of its Class B stockholder liquidity program and inaugural exchange offer
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
GXO Logistics $1.1 billion notes offering
The investment-grade notes are due 2029 and 2034
Bombardier cash tender offer
The company purchased certain debt securities
Uniti Group merger with Windstream
We are advising Uniti Group on the transaction